Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: An institutional experience

Cancer Cytopathology

Volumn 122, Issue 10, 2014, Pages 737-744

  Lastra, Ricardo R ^a   Pramick, Michelle R ^a   Crammer, Cody J ^a   LiVolsi, Virginia A ^a   Baloch, Zubair W ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Afirma; cytology; fine needle aspiration; molecular; thyroid

Indexed keywords

ADENOMATOID TUMOR; ADULT; AFIRMA TEST; AGED; ARTICLE; ATYPIA OF UNDETERMINED SIGNIFICANCE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FINE NEEDLE ASPIRATION CYTOLOGY; FOLLICULAR LESION OF UNDETERMINED SIGNIFICANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID CANCER; THYROID FOLLICULAR ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID TUMOR; CANCER STAGING; CARCINOMA; COHORT ANALYSIS; COMPARATIVE STUDY; CYTODIAGNOSIS; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; ECHOGRAPHY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PATHOLOGY; PROCEDURES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CARCINOMA; COHORT STUDIES; CYTODIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE; ULTRASONOGRAPHY, DOPPLER; YOUNG ADULT;

EID: 84910003787     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21455     Document Type: Article

References (17)

1. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer;, Cooper DS, Doherty GM, et al., Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19: 1167-1214.
2. Baloch ZW, LiVolsi VA, Asa SL, et al., Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008; 36: 425-437.
3. Cibas ES, Ali SZ,. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2009; 19: 1159-1165.
4. Wang CC, Friedman L, Kennedy GC, et al., A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid. 2011; 21: 243-251.
5. Nikiforov YE, Ohori NP, Hodak SP, et al., Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011; 96: 3390-3397.
6. Yip L, Farris C, Kabaker AS, et al., Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. J Clin Endocrinol Metab. 2012; 97: 1905-1912.
7. Alexander EK, Kennedy GC, Baloch ZW, et al., Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012; 367: 705-715.
8. Alexander EK, Schorr M, Klopper J, et al., Multicenter clinical experience with the Afirma gene expression classifier. J Clin Endocrinol Metab. 2014; 99: 119-125.
9. Moses W, Weng J, Sansano I, et al., Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg. 2010; 34: 2589-2594.
10. Ferraz C, Eszlinger M, Paschke R,. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab. 2011; 96: 2016-2026.
11. Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C,. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance. Acta Cytol. 2011; 55: 570-575.
12. Aragon Han P, Olson MT, Fazeli R, et al., The impact of molecular testing on the surgical management of patients with thyroid nodules. Ann Surg Oncol. 2014; 21: 1862-1869.
13. Kleiman DA, Sporn MJ, Beninato T, et al., Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: a prospective case series of 960 patients. Cancer. 2013; 119: 1495-1502.
14. Eszlinger M, Paschke R,. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol Cell Endocrinol. 2010; 322: 29-37.
15. Mazzanti C, Zeiger MA, Costouros NG, et al., Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res. 2004; 64: 2898-2903.
16. Dettmer M, Vogetseder A, Durso MB, et al., MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas. J Clin Endocrinol Metab. 2013; 98: E1-E7.
17. Wong LQ, LiVolsi VA, Baloch ZW,. Clinicopathologic Determinants of Thyroid Fine-Needle Aspiration Specimens Diagnosed as Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance. Presented in poster form at the 2013 American Society of Clinical Pathology Annual Meeting; September 18-21, 2013; Chicago, IL.